Brenda Larsen-Becker - 15 Mar 2023 Form 4 Insider Report for Sight Sciences, Inc. (SGHT)

Role
Director
Signature
/s/ Jeremy Hayden, Attorney-in-Fact for Brenda Becker
Issuer symbol
SGHT
Transactions as of
15 Mar 2023
Net transactions value
-$20,845
Form type
4
Filing time
12 Jun 2023, 17:41:22 UTC
Previous filing
18 Mar 2022
Next filing
10 Jun 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SGHT Common Stock Award $0 +17,923 $0.000000 5,974 15 Mar 2023 Direct F1
transaction SGHT Common Stock Tax liability $20,845 -2,295 -38% $9.08 3,679 15 Mar 2023 Direct F2, F3
transaction SGHT Common Stock Award $0 +15,094 $0.000000 3,679 08 Jun 2023 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person on March 15, 2022 under the Issuer's Non-Employee Director Compensation Program (such grant, the "2022 RSU Grant"), as reported in Table II on the Reporting Person's Form 4 filed with the Securities and Exchange Commission on March 18, 2022. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). Of the RSUs awarded to the Reporting Person under the 2022 RSU Grant, one-third vested on March 15, 2023, and an additional one-third vests on each of March 15, 2024 and March 15, 2025, subject to the Reporting Person's continued service as a director on the Company's board of directors through each such vesting date.
F2 Reflects shares of Common Stock sold to cover the Reporting Person's tax liability in connection with the vesting of the RSUs underlying the 2022 RSU Grant.
F3 Reflects the weighted average price at which the shares of Common Stock were sold. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F4 Reflects a grant of RSUs made to the Reporting Person under the Issuer's Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of Common Stock. The number of RSUs granted is equal to approximately $120,000 of shares of Common Stock as determined by the closing price on the grant date, June 8, 2023. The RSUs vest on the earlier of June 8, 2024 and the date of the Issuer's 2024 annual meeting of stockholders, subject to the Reporting Person's continued service as a director on the Company's board of directors through such vesting date.